Purple Biotech Ltd (PPBT) — Long-term Investment Intensity

Latest as of September 2022: 0.3%

Purple Biotech Ltd (PPBT) has a Long-term Investment Intensity of 0.3% as of September 2022. Long-term investments of ILA187.00K represent 0.3% of total assets of ILA58.54 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Purple Biotech Ltd for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.3%
LT Investments / Total Assets

Long-term Investments

ILA187.00K
ILA

Total Assets

ILA58.54 Million
ILA

Country

Israel
TA

Purple Biotech Ltd Long-term Investment Intensity (2021–2021)

This chart shows how Purple Biotech Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of September 2022, the intensity stands at 0.3%, reflecting long-term investments of ILA187.00K against total assets of ILA58.54 Million ILA. Also explore balance sheet size of Purple Biotech Ltd for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Purple Biotech Ltd (2021–2021)

The table below presents the year-by-year Long-term Investment Intensity for Purple Biotech Ltd from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Purple Biotech Ltd (PPBT) total market value.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2021 0.3% ILA187.00K ILA70.20 Million
pp = percentage points